<DOC>
	<DOCNO>NCT01240213</DOCNO>
	<brief_summary>Experimental human data suggest vitamin D could protect breast cancer . Overweight/obese individual increase risk low vitamin D level . Vitamin D may reduce production fat tissue , thereby reduce weight gain , would result low level adipose-derived hormone breast cancer risk factors.The purpose study test effect vitamin D supplementation response weight loss ( diet + exercise ) intervention select breast cancer risk factor overweight obese postmenopausal woman low blood vitamin D level .</brief_summary>
	<brief_title>Vitamin D , Diet Activity Study</brief_title>
	<detailed_description>Objective : To test incremental effect vitamin D supplementation ( 2000 IU/day ) 228 overweight obese postmenopausal woman low blood vitamin D level response weight loss ( diet + exercise ) intervention double-blind placebo-controlled clinical trial . Primary Aim : • Determine effect 12-months vitamin D supplementation vs. placebo weight loss woman follow weight loss diet exercise program . Secondary Aims : - Determine effect 12-months vitamin D vs. placebo blood biomarkers associate increased breast cancer risk ( insulin , glucose , CRP ) . - Test 12-months vitamin D effect muscle strength measure 1RM leg press bench press woman undergo weight loss . - Test effect 12-month vitamin D supplementation effect quality life ( QOL ) woman undergo weight loss . Additional Aims : - In 50 % subset woman , test effect 12-month vitamin D supplementation vs. placebo breast epithelial cell cytomorphology ( quantified Masood cytology index ) obtain random periareolar fine needle aspiration ( RPFNA ) . - Collect subcutaneous abdominal fat aspiration 50 % subsample woman . OUTLINE : This randomize study . Participants stratify accord body mass index ( &lt; 30 v ≥ 30 ) RPFNA-consent . All participant receive 6-month weight loss intervention ( prescribed weight loss goal 10 % initial body weight ) follow 6 month ' maintenance therapy . Baseline , 6- , 12-month measurement include weight , BMI , waist hip circumference , serum 25-hydroxyvitamin D , fast blood sample , questionnaire detail diet especially item contain vitamin D , physical activity level , sun exposure include clothing sunscreen habit , dietary supplement vitamin use , medication .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Avitaminosis</mesh_term>
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Age 5075 year Postmenopausal ( period past 12 month ) Screening serum vitamin D ( 25 ( OH ) D ) 10 32 ng/mL ( `` insufficient '' ) No menopausal HRT use type include vaginal X 6 month willing avoid use study duration BMI &gt; 25.0 kg/m2 ( &gt; 23.0 Asians ) Physically able undertake calorie reduction exercise program Able come clinic visit , class , measurement , fill questionnaire log English Gives inform consent , agree randomly assign Currently use 400 IU vitamin D supplemental source Screening vitamin D level &lt; 10 ng/mL ( referred primary provider ) &gt; 32 ng/mL ( already sufficient ) Osteoporosis Renal disease , history kidney stone Any contraindication take vitamin D 2000 IU/day Plans leave study area within followup period Plans join another organized weight loss program take appetite suppressant medication study period History bariatric surgery Current use medication likely interfere adherence intervention study outcomes Current smoker Personal history invasive situ breast cancer Personal history invasive cancer breast : except non melanoma skin cancer would eligible Diabetes mellitus Abnormalities screen physical contraindicate participation Severe congestive heart failure per NYHA criterion 3 &amp; 4 Contraindications entry research exercise program : recent ( within 6 month ) myocardial infarction , pulmonary edema , myocarditis , pericarditis , unstable angina , pulmonary embolism , deep vein thrombosis , uncontrolled hypertension ( systolic &gt; 200 , diastolic &gt; 100 ) , orthostatic hypotension , moderate/severe aortic stenosis , uncontrolled arrythmia , uncontrolled congestive heart failure , leave bundle branch block , history cardiac arrest stroke Alcohol drug abuse , significant mental illness ( assess study staff impression ) For RPFNA/adipose tissue substudy : bilateral breast cancer , bilateral mastectomy , unable unwilling stop aspirin NSAIDs 1 week procedure , allergy anesthetic local anesthetic .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>lifestyle intervention</keyword>
	<keyword>postmenopausal woman</keyword>
</DOC>